NHS Breast Screening Programme (London)

NHS England (London Region) has concluded the tender process for the provision of the NHS Breast Screening Programme across London. The procurement, under the Health Care Services (Provider Selection Regime) Regulations 2023, utilised the competitive process, marking the contract as formally awarded. This service falls under the health services category with CPV classification 85100000 and will run initially for five years starting from 1st April 2026, with an option to extend for an additional two years.

The total contract value for the initial five-year period is £168,443,181, which will be disbursed on a cost and volume basis. The process has moved from the tender stage to the award stage, emphasizing the contract's significant scale designed to encompass multiple service providers, integrating both new and existing healthcare entities within London. The awarded contract presents substantial opportunities for healthcare providers in London, especially those with the capacity to deliver large-scale health services.

The procurement specifically seeks entities capable of managing extensive screening services, offering a lucrative prospect for organisations with experience in healthcare provision and management. The competitive nature of the process, emphasizing both quality and cost criteria, indicates that innovative and efficient service delivery models have a strong chance of success. Providers like Royal Free London NHS Foundation Trust and King’s College Hospital NHS Foundation Trust, which have been awarded parts of the contract, highlight the attractiveness of large providers in the healthcare market.

These opportunities could be particularly beneficial for large-scale health service providers aiming to expand their operations or for new entrants looking to establish a foothold in the significant London health services market.